1-8 of 8
Dirk Hellwig
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II frontline chemolight R-pola-glo trial induces high and durable response rates in elderly and medically unfit/frail patients with aggressive B-cell lymphoma

Free
Björn Chapuy, Rebecca Wurm-Kuczera, Ralph Michael, Meng Wang, Petra Pichler, Angela Huster, Andrea Kerkhoff, Michael Panny, Roland Schroers, Anna Ossami Saidy, Fabian Müller, Frederik Damm, Manuel Orlinger, Philipp Staber, Carsten Schwaenen, Luisa Wohn, Clemens Schmitt, Martin Hoffmann, Mathias Hänel, Johannes Duell, Simone Heyn, Stephanie Mayer, Thomas Weber, Peter Reimer, Natalia Magdalena Rotter, Ulf Schnetzke, Bastian von Tresckow, Gabriel Kammerer, Julia Rasvina, Barbara Lehner, Thomas Mika, David Böckle, Corinna Leng, Anna Lena Illert, Bettina Altmann, Birte Friedrichs, Ella Willenbacher, Dimitrios Mougiakakos, Christiane Pott, Salah-Eddin Al-Batran, Andreas Rosenwald, Dirk Hellwig, Sascha Dietrich, Bertram Glass, Georg Lenz, Ulrich Keller, Marita Ziepert, Thomas Melchardt, Richard Greil
Journal: Blood
Blood (2025) 146 (Supplement 1): 61.
https://doi.org/10.1182/blood-2025-61
Published: 2025
Journal Articles

Safety of Front-Line R-Mini-CHOP with or without Acalabrutinib in Older Adults with DLBCL - an Interim Analysis of Serious Adverse Events in the Arched / GLA 2022-1 Randomized, Open-Label, Phase 3 Trial

Free
Konstantinos Christofyllakis, Igor Age Kos, Bettina Altmann, Viola Poeschel, Stephanie Maurer, Vadim Lesan, Jörg-Thomas Bittenbring, Dominic Kaddu-Mulindwa, Zanir Abdi, Manfred Ahlgrimm, Sarah Altmeyer, Octavian Fleser, Gerhard Held, Maike Nickelsen, Martin Dreyling, Florian Zettl, Christian Buske, Georg Lenz, Bertram Glass, Björn Chapuy, Norbert Schmitz, German Ott, Reiner Siebert, Andreas Viardot, Florian Scherer, Roland Schmitz, Andreas Rosenwald, Dirk Hellwig, Nina Neuendorff, Theodoros Vassilakopoulos, Chrysoula Doxani, Pascal Blatt, Oguzhan Nakisli, Susanne Schmidt, Tobias Gaska, Börge Arndt, Matthias Mueller, Hanno Maximilian Witte, Martin Bentz, Volkmar Boehme, Heinz Kirchen, Markus Loeffler, Boris Kubuschock, Niklas Gebauer, Rolf Mahlberg, Julian Topaly, Alexander Bott, Kai Wille, Ralf Ulrich Trappe, Mathias J. Rummel, Gerald Illerhaus, Franziska Brunner, Martin Klump, Ulrich Kaiser, Swen Wessendorf, Iordanis Deligiannis, Bert Hildebrandt, Alexander Kiani, Thomas Illmer, Gabriele Prange-Krex, Kristina Lerch, Matthias Sandmann, Sebastian Broeckling, Uwe Martens, Bastian von Tresckow, Annkristin Heine, Holger F. Hebart, Stephan Stilgenbauer, Lorenz Thurner, Moritz Bewarder, Marita Ziepert
Journal: Blood
Blood (2024) 144 (Supplement 1): 4498.
https://doi.org/10.1182/blood-2024-199685
Published: 2024
Journal Articles

A Randomized, Open-Label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults with Untreated Diffuse Large B-Cell Lymphoma (ARCHED / GLA 2022-1)

Free
Konstantinos Christofyllakis, Viola Poeschel, Bettina Altmann, Stephanie Maurer, Vadim Lesan, Jörg Bittenbring, Igor Age Kos, Dominic Kaddu-Mulindwa, Zanir Abdi, Octavian Fleser, Sarah Altmeyer, Nina Rosa Neuendorff, Maike Nickelsen, Gerhard Held, Martin Dreyling, Florian Zettl, Christian Buske, Georg Lenz, Bertram Glass, Bjoern Chapuy, Norbert Schmitz, Theodoros Vassilakopoulos, German Ott, Reiner Siebert, Andreas Viardot, Florian Scherer, Roland Schmitz, Andreas Rosenwald, Dirk Hellwig, Markus Loeffler, Stephan Stilgenbauer, Lorenz Thurner, Moritz Bewarder, Marita Ziepert
Journal: Blood
Blood (2023) 142 (Supplement 1): 6248.
https://doi.org/10.1182/blood-2023-179200
Published: 2023
Journal Articles

Feasibility and Safety of the First-in-Human Chemotherapy-Light Combination of Rituximab, Polatuzumab Vedotin and Glofitamab in Previously Untreated Aggressive B-Cell Lymphoma Patients Above 60 Years of Age Ineligible for a Fully Dosed R-CHOP - R-Pola-Glo/Ikf-t062, a Study of the Austrian Group for Medical Tumor Therapy (AGMT-NHL-16) and the German Lymphoma Alliance (GLA2022-10)

Free
Thomas Melchardt, Rebecca I Wurm-Kuczera, Bettina Altmann, Petra Pichler, Manuel Orlinger, Michael Panny, Luisa Wohn, Andreas Rosenwald, Dirk Hellwig, Sascha Dietrich, Bertram Glass, Georg Lenz, Ulrich Keller, Marita Ziepert, Richard Greil, Bjoern Chapuy
Journal: Blood
Blood (2023) 142 (Supplement 1): 1734.
https://doi.org/10.1182/blood-2023-188854
Published: 2023
Journal Articles

Nivolumab in Combination with Gemcitabine and Oxaliplatin (GemOx) in Relapse/Refractory T-Cell Lymphoma: Preliminary Results of the Experimental Arm of the Niveau Trial

Free
Roch Houot, MDPhD, Viola Poeschel, MD, Bettina Altmann, PhD, Thomas Illmer, MD, Marc André, MD, Martin Dreyling, MD, Herve Maisonneuve, MD, Herve Tilly, MD PhD, Stephanie Mayer, MD, Rene-Olivier Casasnovas, MD, Steven Le Gouill, MD PhD, Fritz C. Offner, MD PhD, Guillaume Cartron, MD PhD, Andrea Kerkhoff, MD, Thomas Weber, MD, Joerg Hoffmann, MD, Marita Ziepert, PhD, Wolfram Klapper, MD, Emmanuel Itti, MD PhD, Dirk Hellwig, Laurence De Leval, MD, Andreas Rosenwald, MD, Corinne Haioun, MD PhD, Laurent Dercle, MD, Philippe Gaulard, MD PhD, Gerhard Held, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
https://doi.org/10.1182/blood-2020-136941
Published: 2020
Journal Articles

CXCR4-Targeted Positron Emission Tomography Imaging of Central Nervous System B-Cell Lymphoma

Free
Peter Herhaus, MD, Jana Lipkova, Felicitas Lammer, MD, Julia Slotta-Huspenina, MD, Benedikt Wiestler, MD, Tibor Vag, MD, Stefan Habringer, MD, Igor Yakushev, MD, Constantin Lapa, MD, Tobias Pukrop, MD, Dirk Hellwig, MD, Andreas Buck, MD, Martina Deckert, MD, Hans-Jürgen Wester, PhD, Florian Bassermann, MD PhD, Wolfgang Weber, MD, Markus Schwaiger, MD, Björn Menze, PhD, Ulrich Keller, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2900.
https://doi.org/10.1182/blood-2019-126024
Published: 2019
Journal Articles

Role of FDG PET/CT to Detect Bone Marrow Involvement in the Initial Staging of Aggressive Non-Hodgkin Lymphoma

Free
Dominic Kaddu-Mulindwa, MD, Bettina Altmann, PhD, Gerhard Held, MD, Marita Ziepert, PhD, Karin Menhart, MD, Jirka Grosse, MD, Stephanie Angel, Stephan Stilgenbauer, Michael Pfreundschuh, MD, Ken Herrmann, MD PhD, Ulrich Duehrsen, MD, Andreas Hüttmann, MD, Francesco Barbato, Dirk Hellwig, Viola Poeschel, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2892.
https://doi.org/10.1182/blood-2019-128896
Published: 2019
Journal Articles

Excellent Outcome of Elderly Patients with Favourable-Prognosis DLBCL Treated with 4 Cycles CHOP/Chlip-14 Plus 8 Applications of Rituximab and a PET-Based Intensification Strategy That Includes Involved-Site Radiotherapy (IS-RT): Results of the First 120 Patients of the OPTIMAL>60 Trial of the Dshnhl

Free
Michael Pfreundschuh, MD, Niels Murawski, MD, Konstantinos Christofyllakis, Bettina Altmann, Marita Ziepert, PhD, Mathias Haenel, MD, Andreas Viardot, MD, Andreas Neubauer, MD, Gerhard Held, MD, Lorenz Truemper, Christian Schmidt, MD, Lothar Kanz, Kai Huebel, MD, Norbert Schmitz, MD, Tobias Heintges, MD, Heinz Kirchen, MD, Günther Schneider, MD, Christian Ruebe, MD, Christian Berdel, MD, Dirk Hellwig, MD, Jirka Grosse, MD, Viola Poeschel, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1549.
https://doi.org/10.1182/blood.V130.Suppl_1.1549.1549
Published: 2017